Pharmaceutical manufacturing is based on mass production and distribution of medicine. This is a reliable system that ensures reproducibility and high-quality products. However, its lack of flexibility imposes a great limitation in developing new technologies and innovations to improve efficiency and reliability. Below is a discussion on how Patient-Centered Outcomes Research (PCOR) is changing the medical and pharmaceutical landscape.
What is PCOR?
People are faced with many choices to make on medical grounds. However, regardless of the decision made, everybody wants the same thing: the best possible information and outcome. Most clinical research and information that patients need to decide on comes from scientific research. As successful as these researches are, they, most of the time, miss the mark: they deal with situations, outcomes and complexity of the conditions some people don’t have. Because of that, companies like Carenity offer PCOR solutions to support personalised research, providing the necessary information to patients and caregivers to make the right healthcare decision.
The Aim of PCOR
Scientific research is sometimes conducted on different individuals with different conditions, race, sex, age and condition complexity, making it difficult to interpret the results. The PCOR offers relevant, more reliable and useful healthcare information for decision-makers (caregivers and patients). This provides an open platform for easy communication between people and caregivers to make informed healthcare decisions. Additionally, it ensures that their (patients and healthcare providers) ideas, conditions and situations are considered in assessing the best healthcare option.
PCOR assesses the harms and benefits of diagnostic, palliative, preventive, therapeutic or health delivery systems during decision-making, indicating comparisons and results that matter to specific individuals. When making drugs, it focuses on individual needs, preferences and anatomy to ensure people get the outcome they care about, like good quality of life, symptoms, survival and function.
Conclusion
To break barriers and address individual differences, Patient-Centered Outcomes Research takes advantage of several settings and participants’ diversity. It investigates optimising outcomes in medical services and drug manufacturing while dealing with technology, service availability and other stakeholder perspectives. This catalyses and promotes evidence development that is relevant to the health decision made by healthcare providers and people.
